Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.3
Impact Factor 2024
1.5
CiteScore 2024
1.3
Impact Factor 2024
1.5
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Rosacea-like eruptions associated with upadacitinib in atopic dermatitis: two case reports and management strategies

    Claudia Paganini, Edoardo Mortato, Lorenzo Tofani, Alfredo Belcastro, Marina Talamonti, Cosimo Di Raimondo, Luca Bianchi, Marco Galluzzo
    04-03-2025
    https://doi.org/10.4081/dr.2025.10193
    697
    PDF: 506
    HTML: 2
  • Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

    Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi
    13-09-2023
    https://doi.org/10.4081/dr.2023.9839
    2651
    PDF: 968
    HTML: 28
  • Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient Use of upadacitinib in pediatric comorbidities

    Edoardo Mortato, Ludovico Maria Rao, Marina Aloi, Arnaldo Cioni, Enrico Matteini, Angela Fico, Sara Lambiase, Ruslana Gaeta Shumak, Luca Bianchi, Elena Campione, Laura Diluvio
    09-01-2026
    https://doi.org/10.4081/dr.2026.10165
    550
    PDF: 280
  • Atopic dermatitis: a brief review of recent advances in its management

    Sultan Daghafak Alenazi
    23-05-2023
    https://doi.org/10.4081/dr.2023.9678
    2355
    PDF: 1389
    HTML: 98
  • Refractory pityriasis rubra pilaris treated with abrocitinib

    Filip Rob
    09-01-2025
    https://doi.org/10.4081/dr.2025.10105
    380
    PDF: 257
    HTML: 9
  • Psoriasiform eruption induced by dupilumab successfully treated with upadacitinib

    Mattia Minghini, Natale Schettini, Lucrezia Pacetti, Chiara Bocchi, Alessandro Borghi
    16-10-2025
    https://doi.org/10.4081/dr.2025.10588
    218
    PDF: 133
  • Keratosis lichenoides chronica: a case report with dermatoscopic and ultrasonographic analysis

    Katarzyna Korecka, Monika Bowszyc-Dmochowska, Nina Łabędź, Ryszard Żaba, Aleksandra Dańczak-Pazdrowska, Adriana Polańska
    11-06-2025
    https://doi.org/10.4081/dr.2025.10093
    350
    PDF: 256
    HTML: 7
  • Successful use of upadacitinib for the improvement of vitiligo-like and perifollicular dyspigmentation (salt-and-pepper skin) in systemic sclerosis

    Giovanni Paolino, Matteo Riccardo Di Nicola, Santo Raffaele Mercuri, Valentina Canti
    12-02-2026
    https://doi.org/10.4081/dr.2026.10652
    202
    PDF: 127
  • Upadacitinib for the management of refractory hidradenitis suppurativa, psoriasis, and pyoderma gangrenosum

    Giorgia Sbarra, Edoardo Mortato, Francesco Loconsole
    03-02-2026
    https://doi.org/10.4081/dr.2026.10314
    375
    PDF: 214
  • Scabies mimicking relapsing atopic dermatitis

    Flavia Pigliacelli, Elva Abril, Norma Cameli, Paolo Iacovelli, Maria Mariano
    09-08-2024
    https://doi.org/10.4081/dr.2024.10070
    1034
    PDF: 656
    HTML: 93
  • Upadacitinib as a potential option for the management of paradoxical eczema induced by interleukin-23 inhibitors

    Anna Paola Lugli, Niccolò Gori, Elena Ippoliti, Benedetta Ambrosio, Ketty Peris
    03-02-2026
    https://doi.org/10.4081/dr.2026.10644
    461
    PDF: 242
  • Acne exacerbation after tofacitinib treatment for alopecia areata

    Sawsan Alharthi, Mohammed G. Turkmani, Mohammed I. AlJasser
    01-01-2022
    https://doi.org/10.4081/dr.2022.9396
    2596
    PDF: 848
    HTML: 27
  • Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

    Ermira Ziçishti, Migena Vargu, Sabina Dedej, Eriselda Kurushi, Valbona Zenelaj, Ermira Vasili
    13-03-2025
    https://doi.org/10.4081/dr.2025.10021
    426
    PDF: 286
    HTML: 3
1 - 13 of 13 items

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • XXXI Congresso Nazionale Intergruppo Melanoma Italiano (IMI)
    • IMI - Epidemiology, genetics and pathogenesis
    • IMI - Prevention and diagnosis
    • IMI - Pathological and molecular classification
    • IMI - Surgery
    • IMI - Therapy
    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy